Two studies assessed the risk of tumorigenic transformation of human BM- and WAT-derived stromal cells when overexpressing MYC [41,45]; even though higher proliferation rates of MYC overexpressing stromal cells were observed, no signs for malignant transformation or teratoma growth were detected in mouse models. This evidence concerns the gene MYC and teratoma.